Invega 3 mg

INVEGA 3 MG is an extended-release tablet containing palperidone, used to manage certain mental health conditions. This medication is designed for oral administration and is manufactured by Janssen Inc. in Canada.

INVEGA 3 MG is primarily used in the management of schizophrenia and other mental health conditions. Palperidone, the active ingredient, works to help maintain stability in individuals who have been previously treated with this medication. It is often prescribed to support ongoing treatment plans as determined by healthcare providers.

Common effects of INVEGA 3 MG may include drowsiness, dizziness, and weight gain. Some individuals might experience restlessness or tremors. These effects can vary widely among users, and it's important to monitor any changes in physical or mental state while taking this medication.

INVEGA 3 MG should be handled with care, especially by individuals with a history of heart problems, seizures, or diabetes. It is important to follow the guidance of a healthcare provider regarding the use of this medication. Always store the tablets in a cool, dry place away from children and pets.

INVEGA 3 MG may interact with other medications, including those that affect the central nervous system, such as antidepressants or other antipsychotics. Alcohol and certain supplements can also influence the effects of palperidone. It's advisable to discuss all current medications with a healthcare provider before starting INVEGA 3 MG.